Introduction The extent to which physical activity (PA) participation among uterine cancer survivors may be limited by physical and functional impairments (PFIs) related to cancer treatment is unknown. We sought to describe PA participation, characterize the prevalence of PFIs, and examine the association between PFI status and PA participation within this population. Methods We conducted a study using a mailed survey among uterine cancer survivors who received treatment at a university hospital. We asked about PA and PFIs using validated self-report questionnaires. PA was calculated using metabolic equivalent hours per week (MET-hrs·wk−1). PFI was defined as having one or more of the following symptoms: lower limb lymphedema (LLL), general pain, fatigue, or severe bladder, bowel, or pelvic issues. Ordinal logistic regression was used to quantify the odds ratio (OR) between PA and PFIs. Results The response rate to our survey was 43%. Among the 213 study participants, 40%, 13%, 13%, 12%, and 23% reported participating in <3.0, 3.0–8.9, 9.0–17.9, 18.0–26.9, and ≥ 27.0 MET-hrs·wk−1 of PA, respectively. Walking is the preferred mode of exercise for physically active uterine cancer survivors. 53% of survivors experience at least one PFI. The most common PFI is LLL (36.2%), followed by general pain (22.5%). The OR of PFI decreased as MET-hrs·wk−1 of PA increased (OR = 0.51, 95% CI: 0.31–0.84; P=.009). Conclusion The majority of uterine cancer survivors experience physical and functional impairments that significantly reduce the likelihood of PA participation. Physical activity recommendations for uterine cancer survivors should take into account treatment-related impairments that can affect PA participation.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.